NCT06173999View on ClinicalTrials.gov

A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 22, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Peripheral T-cell Lymphoma
Interventions
DRUG

SHR2554/CHOP

SHR2554 with CHOP

DRUG

SHR2554/CHOEP

SHR2554 with CHOEP

Trial Locations (1)

100142

RECRUITING

Beijing Cancer Hospital, Beijing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY